Blog
Real-world evidence on heart failure from GLP-1 and advanced CKD populations
Use of GLP-1 RAs following label expansion for patients with CVD and overweight or obesity
Hematologic oncology at scale: From population insight to patient-level risk signals
Truveta experts: What adolescent sleep disorders reveal about mental health trends
Real-world survival outcomes after cardiac contractility modulation: New research from Impulse Dynamics
Clinical trials: Introducing real-time trial design, optimization, and evidence generation
Why I’m joining Truveta
